Retreatment with sofosbuvir plus grazoprevir/elbasvir plus ribavirin of patients with hepatitis C virus genotype 1 or 4 who previously failed a NS5A or NS3-containing regimen. ANRS HC34 REVENGE. (Q45325577)
Jump to navigation
Jump to search
scientific article published on 25 October 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Retreatment with sofosbuvir plus grazoprevir/elbasvir plus ribavirin of patients with hepatitis C virus genotype 1 or 4 who previously failed a NS5A or NS3-containing regimen. ANRS HC34 REVENGE. |
scientific article published on 25 October 2017 |
Statements
1 reference
Retreatment with sofosbuvir plus grazoprevir/elbasvir plus ribavirin of patients with hepatitis C virus genotype 1 or 4 who previously failed a NS5A or NS3-containing regimen. ANRS HC34 REVENGE. (English)
1 reference
Stanislas Pol
1 reference
Victor de Lédinghen
1 reference
Claire Laforest
1 reference
Christophe Hézode
1 reference
Alain Renault
1 reference
Laurent Alric
1 reference
Dominique Larrey
1 reference
Sophie Métivier
1 reference
Albert Tran
1 reference
Caroline Jézéquel
1 reference
Didier Samuel
1 reference
Fabien Zoulim
1 reference
Christelle Tual
1 reference
Aurélie Pailhé
1 reference
Séverine Gibowski
1 reference
Marc Bourlière
1 reference
Eric Bellissant
1 reference
Jean-Michel Pawlotsky
1 reference
25 October 2017
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference